Account
Watchlists
Bookmarks
Pricing
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2025
Bearish
2
Neutral
7
Bullish
5
Bearish
2
Neutral
7
Bullish
37
Bearish
0
Neutral
0
Bullish
32
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 6 Cr
P/E
50.08
Hemo Organic Ltd, formerly known as Dinesh Allorga Limited, produces and sells white coal, ayurvedic medicines, and chemicals in India.
The company plans a strategic shift by entering the chemical manufacturing space with a new project near Khambhat, Gujarat.
This project focuses on manufacturing 2.6 Di Chloro Aniline and Para Chloro Meta Cresol, crucial in pharmaceuticals and the leather industry respectively.
The project involves a significant investment of Rs.447 lacs, aiming to expand the company's product offerings and market reach.
Trading
Trading - Medium / Small
6 Cr
Low Risk
50.1
35.9
0.3
—
19.45
8.05
Sales CAGR
1Y
11950.00%
3Y
607.06%
5Y
54.17%
10Y
40.81%
Profit CAGR
1Y
161.54%
3Y
—
5Y
—
10Y
—
ROE
TTM
-48.36%
3Y
29.88%
5Y
59.05%
10Y
-166.20%
ROCE
TTM
-3.48%
3Y
-12.31%
5Y
-16.22%
10Y
-38.44%
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
LOW MARGIN
Technicals
Bullish
Risk
MODERATE RISK
Corporate Action
3 hours ago
Notice of Extra-Ordinary General Meeting (EGM)
Hemo Organic Limited is holding an Extra-Ordinary General Meeting on January 7, 2026, to approve key business resolutions including the increase in authorized share capital and issue of convertible warrants.
Extra-Ordinary General Meeting
3 hours ago
Notice of EGM Scheduled for January 2026
Hemo Organic Limited will hold an Extra-Ordinary General Meeting on January 7, 2026, to discuss increasing authorized share capital and issuing convertible warrants.
Board Meeting Outcome
5 days ago
Approval of Capital Increase and Fund Raising
The Board of Hemo Organic Limited approved an increase in authorized share capital and plans to raise funds through the issuance of convertible warrants.
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
14.97 | 6 Cr | — | 6.78 | 0.00 | -21.47 | -9.71 | -3.17 | |
19.45 | 6 Cr | 50.08 | 0.00 | 0.00 | -48.36 | -3.48 | 2.25 | |
— | 6 Cr | — | 1.56 | 0.00 | -4.89 | -4.61 | -4.51 | |
11.05 | 6 Cr | 52.62 | 0.00 | 0.00 | -20.28 | 50.07 | 13.79 | |
9.40 | 6 Cr | 140.86 | 0.00 | 0.00 | -2.30 | 24.28 | 0.57 | |
6.35 | 6 Cr | — | 1.03 | 0.00 | -31.95 | -21.21 | -13.22 | |
0.49 | 6 Cr | — | 0.00 | 0.00 | 544.47 | -166.85 | -591.30 |
